Launch One Acquisition Corp. Terminates Business Combination Agreement with Minovia Therapeutics

summarizeSummary

Launch One Acquisition Corp. announced the mutual termination of its Business Combination Agreement with Minovia Therapeutics Ltd., effective January 30, 2026, and will now seek alternative merger targets.

check_boxKey Events

• Business Combination Agreement Terminated

  Launch One Acquisition Corp. and Minovia Therapeutics Ltd. mutually agreed to terminate their Business Combination Agreement (BCA) as of January 30, 2026.

• Mutual Release of Liabilities

  The termination includes a mutual release of all liabilities and damages related to the transaction documents and proposed merger.

• Search for New Business Combination

  The company and its sponsor intend to seek alternative ways to consummate an initial business combination.

auto_awesomeAnalysis

Launch One Acquisition Corp. has mutually agreed to terminate its Business Combination Agreement (BCA) with Minovia Therapeutics Ltd., effective January 30, 2026. This follows a previous 425 filing on January 13, 2026, which highlighted patent grants for Minovia, indicating the deal was still active. The termination includes all ancillary agreements and a mutual release of liabilities between the parties. While the company states an intent to seek alternative business combinations, the termination of a definitive merger agreement introduces significant uncertainty and delays the de-SPAC process, which is a critical event for a SPAC.